Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-02-03 00:00:00 ET · period of report 2023-01-31 · accession 0001562180-23-000950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | SNDX | Ordentlich Peter | CSO | S - Sale | $28.43 | -69 | 0 | -100% | -$1,962 |
| D | 2023-02-03 | 2023-01-31 | SNDX | Ordentlich Peter | CSO | J - Other | $17.32 | +69 | 69 | New | +$1,195 |
| D | 2023-02-03 | 2023-02-02 | SNDX | Ordentlich Peter | CSO | A - Grant | $28.55 | +90.0K | 90.0K | New | +$2.57M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | S | D | 69 | $28.43 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-31 | J | A | 69 | $17.32 | 69 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2023-02-02 | A | A | 90,000 | $28.55 | 90,000 | D | $28.55 · — to 2033-02-02 | 90,000 Common Stock | (F2) 1/48th of the shares subject to the option shall vest monthly over a four-year period. |